The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis
- 28 August 2013
- journal article
- research article
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 55 (5), 1038-1048
- https://doi.org/10.3109/10428194.2013.827789
Abstract
Radiotherapy is regarded as a primary treatment for early stage extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTL). However, whether combined modality treatment (CMT) comprising radiotherapy and chemotherapy is necessary remains controversial. A systematic review and meta-analysis of studies was performed to evaluate the significance of combining radiotherapy with chemotherapy for early stage ENKTL. Comparison of CMT and radiotherapy alone (RT) showed no significant difference by the measurement of complete response (CR) (odds ratio [OR] 1.07; 95% confidence interval [CI] 0.73–1.58; p = 0.73), 5-year overall survival rate (OS) (HR 0.73; 95% CI 0.45–1.19; p = 0.21) and progression-free survival rate (PFS) (HR 0.76; 95% CI 0.50–1.17; p = 0.21). Additional chemotherapy did not decrease systemic failure (OR 1.52; 95% CI 0.97–2.40; p = 0.07), as well as locoregional failure (OR 0.94; 95% CI 0.52–1.73; p = 0.85). The results may support the assertion that the combination of radiotherapy with chemotherapy cannot improve treatment outcomes, but rather it increases adverse effects and financial costs. However, these results should be interpreted with caution.Keywords
This publication has 67 references indexed in Scilit:
- Extranodal NK/T-cell Lymphoma, Nasal TypeThe American Journal of Surgical Pathology, 2013
- Immunomorphologic profile and Epstein–Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South IndiaLeukemia & Lymphoma, 2012
- Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminologyJournal of Oral and Maxillofacial Pathology, 2011
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma ProjectBlood, 2009
- Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell LymphomaClinical Cancer Research, 2009
- The Spectrum of Epstein-Barr Virus-Associated Lymphoproliferative Disease in Korea: Incidence of Disease Entities by Age GroupsJournal of Korean Medical Science, 2008
- Primäre nasale NK/T-Zell-LymphomeHNO, 2007
- Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapyEuropean Journal Of Cancer, 2005
- The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid TissuesAnnals of Oncology, 1999
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994